Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Boos

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
Expert Review of Cardiovascular Therapy|August 4, 2005
Ximelagatran for stroke prevention in atrial fibrillationChristopher J Boos, Gregory Y H Lip
Journal of the American College of Cardiology|February 21, 2006
Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockersChristopher J Boos, Gregory Y H Lip
American Journal of Hypertension|May 2, 2006
Urotensin and cardiovascular risk among patients with end-stage renal disease: fact or fiction?Christopher J Boos, Gregory Y H Lip
Expert Opinion on Investigational Drugs|November 30, 2004
Novel therapies for the prevention of strokeChristopher J Boos, Gregory Y H Lip
Arteriosclerosis, Thrombosis, and Vascular Biology|January 21, 2006
Assessment of hemostatic risk factors in predicting arterial thrombotic eventsChristopher J Boos, Gregory Y H Lip
The American Journal of Cardiology|September 26, 2006
C-reactive protein and lone atrial fibrillation: potential confoundersChristopher J Boos, Gregory Y H Lip
Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 2005
Ethnic differences in arterial responses, inflammation, and metabolic profiles: possible insights into ethnic differences in cardiovascular disease and strokeGregory Y H Lip, Christopher J Boos
Journal of Clinical Hypertension (Greenwich, Conn.)|January 18, 2024
Ambulatory arterial stiffness index, mortality, and adverse cardiovascular outcomes; Systematic review and meta-analysisChristopher J Boos, Aung Hein, Ahmed Khattab
Thrombosis Research|April 22, 2006
Ximelagatran: an eulogyChristopher J Boos, Gregory Y H Lip
Journal of Thrombosis and Thrombolysis|November 2, 2005
Biomarkers in atrial fibrillation: further observations on biologic plausibility, cause and effectChristopher J Boos, Gregory Y H Lip
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Expert Review of Cardiovascular Therapy|August 4, 2005
Ximelagatran for stroke prevention in atrial fibrillationChristopher J Boos, Gregory Y H Lip
Journal of the American College of Cardiology|February 21, 2006
Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockersChristopher J Boos, Gregory Y H Lip
American Journal of Hypertension|May 2, 2006
Urotensin and cardiovascular risk among patients with end-stage renal disease: fact or fiction?Christopher J Boos, Gregory Y H Lip
Expert Opinion on Investigational Drugs|November 30, 2004
Novel therapies for the prevention of strokeChristopher J Boos, Gregory Y H Lip
Arteriosclerosis, Thrombosis, and Vascular Biology|January 21, 2006
Assessment of hemostatic risk factors in predicting arterial thrombotic eventsChristopher J Boos, Gregory Y H Lip
The American Journal of Cardiology|September 26, 2006
C-reactive protein and lone atrial fibrillation: potential confoundersChristopher J Boos, Gregory Y H Lip
Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 2005
Ethnic differences in arterial responses, inflammation, and metabolic profiles: possible insights into ethnic differences in cardiovascular disease and strokeGregory Y H Lip, Christopher J Boos
Journal of Clinical Hypertension (Greenwich, Conn.)|January 18, 2024
Ambulatory arterial stiffness index, mortality, and adverse cardiovascular outcomes; Systematic review and meta-analysisChristopher J Boos, Aung Hein, Ahmed Khattab
Thrombosis Research|April 22, 2006
Ximelagatran: an eulogyChristopher J Boos, Gregory Y H Lip
Journal of Thrombosis and Thrombolysis|November 2, 2005
Biomarkers in atrial fibrillation: further observations on biologic plausibility, cause and effectChristopher J Boos, Gregory Y H Lip
Pageof 11